Abstract: A capsule beverage machine (1) has: a passage (2) for evacuating used capsules (100); a capsule collector (10) having a bottom (11) and sidewalls (12,12?) delimiting a cavity (13) with a cavity entry opening (14) and a cavity volume for storing the used capsules (100); and a seat (20) into which the evacuation passage (2) leads, the collector (10) having a collection position in which the collector (10) is removably located in the seat (20) for collecting capsules (100) delivered via the passage (2) and the entry opening (14). The seat (20) and the collector (10) are configured to adjust the cavity volume of the cavity (13) so that the cavity volume is smaller when the collector (10) is located in the seat and larger at removal of the collector (10) from the seat. The sidewalls (12,12?) include at least one sidewall (12?) that is movably mounted in the collector (10). The seat (20) and/or the movable sidewall (12?) has an interacting seat member (21).

Abstract: The present invention relates to flavour generation. In particular the invention relates to a method for flavour generation in a heat-treated food product using a prolidase enzyme. The invention also relates to a heat-treated food product prepared according to the method of the invention.

Abstract: Medium chain fatty acids or a composition comprising medium chain fatty acids for use in the prevention or treatment of cardiac enlargement, valvular heart disease and/or a condition associated with either of the foregoing in a human.

Abstract: The present invention relates to a soluble beverage powder of dried coffee extract. In particular to a soluble coffee powder having a gold appearance. Further aspects of the invention are a powder mix for preparing a beverage and a process for making a soluble beverage powder.

Abstract: The present invention relates to a composition comprising a dispersion of dietary fibre particles in fat. In particular, a composition wherein the dietary fibre particles comprise water. Further aspects of the invention include the use of the composition to reduce saturated fatty acid content, a process for preparing the composition and a food product.

Abstract: A composition comprising one or more polyphenols, such as oleuropein, rutin, curcumin or quercetin, can treat or prevent sarcopenia, reduce a loss of muscle functionality (e.g. muscle strength, gait speed, etc.), increase muscle functionality, and/or improve recovery of muscle functionality after muscle atrophy. The composition can be administered to an individual who is elderly and/or frail.

Abstract: A method for roasting coffee beans comprising the steps of a) heating the coffee beans until the temperature of the coffee beans is at least 180° C.; b) injecting a stream of oxygen-containing gas into the flow of hot air after the burner; and c) maintaining the injection of the stream of oxygen-containing gas until the end of the roasting process to mitigate the concentration of carbon monoxide in the roasting chamber, and wherein the coffee beans are roasted in a rotating fluidized bed roaster.

Abstract: A method of attenuating, treating or preventing cognitive aging in an individual who does not have dementia includes administering to the individual a therapeutically effective amount of a composition containing an omega-3 fatty acid and choline. The method can achieve a benefit that is one or more of decreasing brain atrophy, increasing or maintaining number of synapses, increasing amyloid-? phagocytosis, or decreasing or maintaining neuroinflammation in the non-demented individual. The method can prevent dementia in an individual at risk thereof, for example an elderly human. The composition can be administered to the individual in a daily dose that provides 5.5 mg/day to 5,500 mg/day of the choline, for example 85 mg/day to 3,500 mg/day of the choline.

Abstract: A mobile liquid tank is disclosed that includes an insulated tank body and two heating elements. Also disclosed is a liquid heating system comprising the mobile liquid tank, as well as methods of heating a liquid using the mobile liquid tank.

Abstract: A pet food composition specifically formulated for a small dog can include a combination of specific amino acids and probiotics to maintain or increase absorption of amino acids. Methods of increasing absorption of amino acids are also provided.

Abstract: The present invention relates to a dispensing device (10) for dispensing a food product from a exchangeable multi-dose container (1), the device comprising a support (9) for removably supporting the container (1), a sealable dosing chamber (4) for receiving, dosing and holding a dose of food product dispensed from the container (1), oxygen reducing means (5) designed for reducing oxygen level in the dosing chamber (4), characterized in that the device further comprises at least one piston (7) arranged to move relatively to the support (9) of the device, and configured to at least partially enclose the dosing chamber (4) in an initial sealingly engaged position of the piston with the support (9), the piston (7) being designed for selectively opening the container (1) by moving relatively to the support (8) and for enabling the dosing chamber (4) to be charged with the dose of food product in an extended and sealingly disengaged position of the piston (7) relative to the support (9).

Abstract: The invention concerns a process for preparing a tea in a drinking receptacle with a tea brewing machine, said machine being configured:—to brew tea from a capsule, said capsule comprising tea leaves, by introducing hot water in said capsule and dispensing brewed tea from the capsule in the drinking receptacle, and—to pump and heat water and dispense hot water to the capsule, wherein said process comprises a step of pasteurization of tea leaves inside the capsule before dispensing brewed tea from the capsule inside the drinking receptacle, wherein said pasteurization step comprises the sub-steps of: p1)—introducing hot water in the capsule until all the tea leaves are submerged by hot water inside the capsule and stopping water introduction before tea is dispensed therefrom in the drinking receptacle, then p2) keeping all the tea leaves submerged in hot water during a period of time, wherein the temperature of hot water introduced in sub-step p1) and the sum of the periods of time of sub-steps p1) and p2) bef

Abstract: A process for reducing the monosaccharide and/or disaccharide content in a food material, the process comprising contacting the food material with a glucosyltransferase that comprises an amino acid sequence having at least 95% identity to SEQ ID NO: 1.

Abstract: An L-menthol pharmaceutical dosage form includes an effective amount of L-menthol for treating a gastrointestinal disorder. The L-menthol is within a plurality of particulates having a core and an enteric coating over the core. The core includes an L-menthol source that is at least 80% pure L-menthol. The dosage form may be used to treat gastrointestinal disorders, such as irritable bowel syndrome.

Abstract: The invention relates to a cartridge (1) for preparation of a beverage upon injection of liquid into the cartridge, the cartridge comprising at least a first compartment (2) and a second compartment (3) for holding beverage ingredients, an injection area (4) for receiving a liquid injected into the cartridge, and flow dividing means (8) designed for providing a fluid communication between the injection area (4) and the first and second compartment (2, 3), wherein the flow dividing means (8) are designed to provide a preferred flow path for liquid from the injection area (4) to the first and second compartment [2, 3) and to outlet means (9, 10) of the cartridge.

Abstract: The present invention relates to compositions comprising galactooligosaccharides (GOS) and probiotic bacteria obtained by a process comprising the step of growing the bacteria in a medium comprising GOS, such composition having the effect of boosting the synbiotic effect of the probiotic bacteria with the GOS. Health benefits of the probiotic bacteria as obtained by such a fermentation process are also contemplated.

Abstract: The present invention provides engineered amylase polypeptides and compositions thereof. The engineered amylase polypeptides have been optimized to provide improved thermostability, protease stability, and stability under a range of pH conditions, including acidic (pH<7) conditions. The invention also relates to the use of the compositions comprising the engineered amylase polypeptides for therapeutic and/or nutritional purposes. The present invention also provides polynucleotides encoding the engineered amylase polypeptides, as well as methods for making the engineered polynucleotides and amylase polypeptides.

Abstract: Methods of making mixed allergen products are provided, wherein the mixed allergen products are substantially free of replication viable organisms.

Abstract: The present invention relates generally to the field of foams. One aspect of the invention provides a foam having a continuous lipid phase and a porosity of between 1 and 80% wherein, at a temperature at which the lipid phase has a solid lipid content between 0.1 and 80% the foam comprises gas bubbles having at least 50% of their surface occupied by crystals comprising triglycerides. Further aspects of the invention are a product comprising a foam and a process for forming a foam.